Naito H, Nishida H, Isomura T, Eriguchi N, Sawada T, Tomokiyo A, Tokuyasu T, Fuchigami K, Kuwahara Y, Miyosi A
Gan No Rinsho. 1984 Sep;30(11):1384-91.
CEA was localized in the luminal border, cytoplasm, but not in mucus, in Signet ring cell carcinoma (sig) and mucinous carcinoma (muc). Electronmicroscopically, CEA was localized in the glycocalyx of the microvilli and microvesicles of the cytoplasm. The histologically different cancer types showed no difference in the localization of T-CEA. We also studied P-CEA elevating factors in 38 CEA-positive (++) patients manifesting subserosal (ss) or deeper invasion. No remarkable findings were obtained. When P-CEA elevating factors were studied in 20 patients with (+) CEA reaction and ss or deeper invasion, we found that the incidence of por was high in P-CEA negative cases. In particular, the por incidence was significantly low (p less than 0.01) in patients with scirrhous type. High P-CEA levels were detected in blood adjacent to the cancer. Among 6 cases with negative P-CEA in the vessels adjacent to the cancer whose T-CEA reactions were (++) or (+), and who manifested ss or deeper invasion, there was a high incidence of por (5 cases) and scirrhous type (4 cases), histologically.
在印戒细胞癌(sig)和黏液腺癌(muc)中,癌胚抗原(CEA)定位于管腔边界、细胞质,但不在黏液中。电子显微镜下,CEA定位于微绒毛的糖萼和细胞质的微泡中。组织学上不同的癌症类型在T-CEA的定位上没有差异。我们还研究了38例表现为浆膜下(ss)或更深浸润的CEA阳性(++)患者的P-CEA升高因素。未获得显著结果。当研究20例CEA反应为(+)且有浆膜下或更深浸润的患者的P-CEA升高因素时,我们发现P-CEA阴性病例中门静脉癌栓(por)的发生率较高。特别是,在硬癌类型的患者中,门静脉癌栓发生率显著较低(p小于0.01)。在癌旁血液中检测到高P-CEA水平。在6例癌旁血管中P-CEA阴性、T-CEA反应为(++)或(+)且表现为浆膜下或更深浸润的病例中,组织学上门静脉癌栓发生率较高(5例),硬癌类型发生率较高(4例)。